Pluristem Therapeutics Inc. Share Price Nasdaq
Equities
US72940R1023
Biotechnology & Medical Research
Sales 2022 | 234K 18.65M | Sales 2023 | 287K 22.87M | Capitalization | 32.98M 2.63B |
---|---|---|---|---|---|
Net income 2022 | -41M -3.27B | Net income 2023 | -28M -2.23B | EV / Sales 2022 | 58 x |
Net cash position 2022 | 26.21M 2.09B | Net cash position 2023 | 10.27M 818M | EV / Sales 2023 | 79.1 x |
P/E ratio 2022 |
-0.96
x | P/E ratio 2023 |
-1.04
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 76.12% |
Managers | Title | Age | Since |
---|---|---|---|
Yaky Yanay
CEO | Chief Executive Officer | 52 | 31/10/06 |
Director of Finance/CFO | 40 | 30/04/13 | |
Zami Aberman
CHM | Chairman | 70 | 25/09/05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 73 | 14/07/21 | |
Lorne Abony
BRD | Director/Board Member | 55 | 10/07/23 |
Zami Aberman
CHM | Chairman | 70 | 25/09/05 |
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |